IONS vs PG · rev $226.6M vs P/E 25, rev $84.28B
Ionis Pharmaceuticals Inc (IONS) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
IONS currently screens at market cap $12.28B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the IONS and PG stock pages for the full models.
Not investment advice.